All the news Showing 10 of 938 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Transmission, epidemiology and prevention New cases of hepatitis C declining in people with HIV as access to treatment broadens Keith Alcorn / 21 February 2022 The availability of direct-acting antivirals has led to a 50% reduction in new cases of hepatitis among people with HIV in some high-income settings, a six-country study presented this week ... Hepatocellular carcinoma (HCC) Antihistamine use halved the risk of liver cancer in people with viral hepatitis Keith Alcorn / 08 February 2022 Antihistamines used for relief of allergies and hay fever halved the risk of developing hepatocellular carcinoma (HCC; liver cancer) in people with viral hepatitis during a ten-year follow-up period, a review of ... Hepatitis delta Bulevirtide for hepatitis D proves effective in real-world studies Liz Highleyman / 25 January 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load and improved liver enzyme levels in real-world studies in France and Austria, according to findings presented ... Treatment for people who use drugs Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... HIV Re-infection with hepatitis C has fallen among people with HIV in Europe Keith Alcorn / 20 January 2022 The rate of re-infection with hepatitis C has fallen sharply among people with HIV in Europe since the introduction of direct-acting antivirals, the EuroSIDA cohort study reports in the journal HIV Medicine. People ... Injecting drug use One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... HIV and HBV Hepatitis B may increase cancer risk in people with HIV Keith Alcorn / 29 December 2021 People with both HIV and hepatitis B have a higher rate of non-liver cancers compared to other people with HIV, a large European study has found. The study investigators, who have published ... Hepatocellular carcinoma (HCC) Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Antiviral therapy Hepatitis B treatment for all who need it an "achievable public health goal" for Malawi Keith Alcorn / 13 December 2021 Providing hepatitis B treatment for everyone who needs it in Malawi is an achievable public health goal, researchers from the Malawi-Liverpool-Wellcome Trust programme report, following community surveys in Blantyre, Malawi. Hepatitis B treatment ... Sexual transmission Australia on track to eliminate hepatitis C among gay and bisexual men before 2030 Krishen Samuel / 10 December 2021 Access to direct-acting antivirals to cure hepatitis C has slashed incidence rates for groups most affected in Australia. Among gay and bisexual men living with HIV, incidence fell by 78% ... ← Prev1...34567...94Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive